. Author manuscript; available in PMC: 2020 Jan 6.

Published in final edited form as: J Am Board Fam Med. 2019 Jan-Feb;32(1):37–49. doi: 10.3122/jabfm.2019.01.180155

Table 2:

Process Measures

	Pre-Intervention	Post-Intervention	p-value
Asthma severity assessed
Spirometry performed (#; % of patients)	32 (1.2%)	272 (10.1%)	0.003^1,2
ACT assessed (#; % of patients)	0 (0.0%)	310 (11.5%)	N/A
HEDIS measures
Patients meeting inclusion criteria for HEDIS definition of persistent asthma (% of study sample)	129 (4.8%)	228 (8.5%)	<0.0001¹
Asthma medication ratio: percentage identified as having persistent asthma who had a ratio of controller medications to total asthma medications of 0.50 or greater	52.3%	58.5%	0.3
Medication management for people with asthma: percentage identified as having persistent asthma who were dispensed an asthma controller medication that they remained on for at least
75% of their treatment period	27.6%	34.2%	0.2
50% of their treatment period	56.9%	63.2%	0.3

All p-values in this table obtained using generalized linear mixed models with random effects to control for variability between clinics. Random effects for subject were included when applicable (1), and random treatment effects by clinic were included when significant (2).